Pharmacological characterization of nociceptin receptor: An in vitro study

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 6, 1997, Pages 713-718

  Calò, Girolamo ^a   Rizzi, Anna ^a   Bodin, Mirian ^a   Neugebauer, Witold ^b   Salvadori, Severo ^a   Guerrini, Remo ^a   Bianchi, Clementina ^a   Regoli, Domenico ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Bioassay; Guinea pig ileum; Mouse vas deferens; Nociceptin and nociceptin analogues; Nociceptin receptor

Indexed keywords

NEUROPEPTIDE; NOCICEPTIN; RECEPTOR;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; GUINEA PIG; HUMAN; HUMAN TISSUE; ILEUM; IN VITRO STUDY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; VAS DEFERENS;

EID: 0030726644     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y97-055     Document Type: Conference Paper

References (24)

1. Arunlakshana, O., and Schild, H.O. 1959. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14: 48-58.
2. Berzetei-Gurske, I.P., Schwartz, R.W., and Toll, L. 1996. Determination of activity for nociceptin in the mouse vas deferens. Eur. J. Pharmacol. 302: R1-R2.
3. Calò, G., Rizzi, A., Bogoni, G., Neugebauer, W., Salvadori, S., Guerrini, R., Bianchi, C., and Regoli, D. 1996. The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur. J. Pharmacol. 311: R3-R5.
4. Dooley, C.T., and Houghten, R.A. 1996. Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sci. 59: 23-29.
5. Giuliani, S., and Maggi, C.A. 1996. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br. J. Pharmacol. 118: 1567-1569.
6. Hughes, J., Kosterlitz, H.W., and Leslie, F.M. 1975. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Br. J. Pharmacol. 53: 371-381.
7. Jenkinson, D.H., Barnard, E.A., Hoyer, D., Humphrey, P.P.A., Leff, P., and Shankley, N.P. 1995. International Union of Pharmacology Committee on receptor nomenclature and drug classification. XI. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev. 47: 255-266.
8. Julius, D. 1995. Home for an orphan endorphin. Nature (London), 377: 476.
9. Meunier, J.C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.L., Guillemot, J.C., Ferrara, P., Monserrat, B., Mazarguil, H., Vassart, G., Parmentier, M., and Costentin, J. 1995. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature (London), 377: 532-535.
10. Oka, T., Negishi, K., Suda, M., Matsumiya, T., Inazu, T., and Ueki, M. 1980. Rabbit vas deferens: a specific bioassay for opioid κ-receptor agonists. Eur. J. Pharmacol. 73: 235-236.
11. Paton, W.D.M. 1957. The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea pig ileum. Br. J. Pharmacol. 12: 119-127.
12. Pelton, J.T., Gulya, K., Hruby, V.J., Piper Duckles, S., and Yamamura, H.I. 1985. Conformationally restricted analogs of somatostatin with high μ-opiate receptor specificity. Proc. Natl. Acad. Sci. U.S.A. 82: 236-239.
13. Portoghese, P.S., Lipkowski, A.W., and Takemori, A.E. 1987. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci. 40: 1287-1292.
14. Regoli, D., Boudon, A., and Fauchere, J.L. 1994a. Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46: 551-599.
15. Regoli, D., Gobeil, F., Nguyen, Q.T., Jukic, D., Seoane, P.R., Salvino, J.M., and Sawutz, D.G. 1994b. Bradykinin receptor types and B2 subtypes. Life Sci. 55: 735-749.
16. Reinscheid, R.K., Nothacker, H.P., Bourson, A., Ardati, A., Henningsen, R.A., Bunzow, J.R., Grandy, D.K., Langen, H., Monsma, F.J., Jr., and Civelli, O. 1995. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science (Washington, D.C.), 270: 792-794.
17. Reisine, T. 1995. Opiate receptors. Neuropharmacology, 34: 463-472.
18. Rowe, P.M. 1996. Excitement over orphanin FQ/nociceptin. Lancet, 347: 606.
19. Saito, Y., Maruyama, K., Saido, T.C., and Kawashima, S. 1995. N23K, a gene transiently up-regulated during neural differentiation, encodes a precursor protein for a newly identified neuropeptide nociceptin. Biochem. Biophys. Res. Commun. 217: 539-545.
20. Salvadori, S., Attila, M., Balboni, G., Bianchi, C., Bryant, S.D., Crescenzi, O., Guerrini, R., Picone, D., Tancredi, T., Temussi, P.A., and Lazarus, L.H. 1995. δ Opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Mol. Med. 1: 678-689.
21. Schild, H.O. 1947. pA, a new scale for the measurement of drug antagonism. Br. J. Pharmacol. 2: 189-202.
22. Tallarida, R.J., and Murray, R.B. 1987. Manual of pharmacologic calculations with computer programs. Springer Verlag, New York.
23. Vanhoutte, P.M., Humphrey, P.P.A., and Spedding, M. 1996. X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol. Rev. 48: 1-2.
24. Vaughan, C.W., and Christie, M.J. 1996. Increase by the ORL1 receptor (opioid receptor-like) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br. J. Pharmacol. 117: 1609-1611.